Table 1.
Characteristics of the study population aged 20 and older: exposures in person-years, number of death cases, and number of incident cases by sex and time period.
| Men | Women | ||||||
|---|---|---|---|---|---|---|---|
| Period 1 | Period 2 | Period 3 | Period 1 | Period 2 | Period 3 | ||
| Person-years at risk | Total | 2,810,704 (100%) | 3,278,098 (100%) | 3,487,981 (100%) | 2,885,139 (100% | 3,169,049 (100%) | 3,406,880 (100%) |
| Lower income | 1,270,498 (45%) | 1,410,850 (43%) | 1,339,464 (38%) | 2,195,213 (76%) | 2,337,882 (74%) | 2,281,654 (67%) | |
| Higher income | 1,540,205 (55%) | 1,867,248 (57%) | 2,148,516 (62%) | 689,927 (24%) | 831,167 (26%) | 1,125,226 (33%) | |
|
Number of incident cases
and crude mean age at incidence |
Total cancer (C00-C97) | 39,184 (100%) 69 yr |
40,885 (100%) 69 yr |
36,765 (100%) 69 yr |
39,924 (100%) 70 yr |
39,468 (100%) 70 yr | 36,601 (100%) 69 yr |
| Colon cancer (C18-C20) | 4,511 (12%) 71 yr |
4,642 (11%) 71 yr |
4,032 (11%) 71 yr |
4,774 (12%) 75 yr |
4,563 (11%) 75 yr |
3,775 (10%) 75 yr |
|
| Lung cancer (C33-C34) | 4,981 (13%) 69 yr |
5,210 (13%) 69 yr |
4,809 (13%) 69 yr |
2,006 (5%) 70 yr |
2,406 (6%) 69 yr |
2,428 (7%) 70 yr |
|
| Stomach cancer (C16) | 1,301 (3%) 70 yr |
1,215 (3%) 70 yr |
1,007 (3%) 69 yr |
1,113 (3%) 75 yr |
1,038 (3%) 73 yr |
822 (2%) 73 yr |
|
| Skin cancer (C43) |
1,173 (2%) 65 yr |
1,627 (4%) 65 yr |
1,584 (4%) 65 yr |
1,512 (4%) 65 yr |
1,971 (5%) 64 yr |
2,101 (6%) 63 yr |
|
| Prostate cancer (C61) | 9,294 (24%) 72 yr |
8,893 (22%) 72 yr |
7,419 (20%) 73 yr |
– | – | – | |
| Breast cancer (C50) | – | – | – | 11,386 (29%) 68 yr |
10,971 (28%) 68 yr |
9,567 (26%) 68 yr |
|
| Cervix uteri (C53) | – | – | – | 1,093 (2%) 59 yr |
1,224 (3%) 56 yr |
1,365 (4%) 55 yr |
|
| Other cancer | 17,924 (46%) 67 yr |
19,298 (47%) 66 yr |
17,914 (49%) 67 yr |
18,040 (45%) 71 yr |
17,295 (44%) 70 yr |
16,543 (45%) 70 yr |
|
| Number of deaths | Total deaths | 58,584 (100%) | 58,016 (100%) | 55,393 (100%) | 79,397 (100%) | 72,906 (100%) | 67,328 (100%) |
| Total cancer (C00-C97) | 15,870 (27%) | 15,213 (26%) | 13,421 (24%) | 14,223 (18%) | 12,515 (17%) | 11,143 (17%) | |
| Colon cancer (C18-C20) | 1,667 (3%) | 1,603 (3%) | 1,390 (3%) | 1,915 (2%) | 1,619 (2%) | 1,296 (2%) | |
| Lung cancer (C33-C34) |
3,842 (6%) | 3,829 (6%) | 3,409 (6%) | 1,499 (2%) | 1,691 (2%) | 1,603 (2%) | |
| Stomach cancer (C16) |
775 (1%) | 636 (1%) | 537 (1%) | 672 (1%) | 523 (1%) | 422 (1%) | |
| Skin cancer (C43) |
183 (0.3%) | 186 (0.3%) | 174 (0.3%) | 231 (0.3%) | 185 (0.3%) | 185 (0.3%) | |
| Prostate cancer (C61) |
1,783 (3%) | 1,640 (3%) | 1,324 (2%) | – | – | – | |
| Breast cancer (C50) |
– | – | – | 2,009 (3%) | 1,711 (2%) | 1,434 (2%) | |
| Cervix uteri (C53) |
– | – | – | 246 (0.3%) | 195 (0.3%) | 182 (0.3%) | |
| Other cancer | 7,620 (13%) | 7,319 (13%) | 6,587 (12%) | 7,651 (10%) | 6,591 (9%) | 6,021 (9%) | |
Period 1 (January 2006 to April 2010), period 2 (May 2010 to August 2014), period 3 (September 2014 to December 2018); percentages refer always to the respective total of person-years at risk, number of deaths, and the number of incident cases by period; yr ; years.